Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis

Clinical trial NCT00659971 · COMPLETED

Trial details

NCT number: NCT00659971
Sponsor: Pacgen Biopharmaceuticals Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Oral Candidiasis

Start date: 2008-01-01
Primary completion: 2008-06-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.